Neonatal transient pseudohypoparathyroidism: could it be included among inactivating parathyroid hormone (PTH)/PTH-related protein signalling disorders?
Annals of Pediatric Endocrinology & Metabolism
;
: 129-132, 2019.
Article
in English
| WPRIM
| ID: wpr-762600
ABSTRACT
We report a case of transient pseudohypoparathyroidism in a full-term newborn that presented at 20 hours of life with hypocalcemic seizures, hyperphosphatemia and raised parathormone levels. The diagnosis of pseudohypoparathyroidism was made according to biochemical investigations. The infant was treated with calcium supplementation and vitamin D analog therapy, and he remained stable and symptom-free with normal serum biochemistries during follow-up. We suggest that transient pseudohypoparathyroidism of the newborn (ntPHP) might be included among inactivating parathyroid hormone (PTH)/PTH-related protein signaling disorders as defined by the classification schema recently proposed by the European Pseudohypoparathyroidism Network. To the best of our knowledge, this is the first report in which the new classification has been applied to a case of ntPHP.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Parathyroid Hormone
/
Pseudohypoparathyroidism
/
Seizures
/
Vitamin D
/
Calcium
/
Follow-Up Studies
/
Classification
/
Diagnosis
/
Hyperphosphatemia
/
Precision Medicine
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Humans
/
Infant
/
Infant, Newborn
Language:
English
Journal:
Annals of Pediatric Endocrinology & Metabolism
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS